Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis

Autor: Conceição, Katia, Konno, Katsuhiro, de Melo, Robson Lopes, Antoniazzi, Marta M., Jared, Carlos, Sciani, Juliana M., Conceição, Isaltino M., Prezoto, Benedito C., de Camargo, Antônio Carlos Martins, Pimenta, Daniel C.

Publikováno v: In Peptides 2007 28(3):515-523

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model.

Autor: Ferreira AK; Department of Immunology, Laboratory of Tumor Immunology, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, SP, Brazil.; Alchemypet, Veterinary Dignostic Medicine, CIETEC/IPEN, Department of Oncology, University of Sao Paulo, Sao Paulo, Brazil., Cristofaro B; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, Paris, France., Menezes MC; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil., de Oliveira AK; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil., Tashima AK; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil.; Department of Biochemistry, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil., de Melo RL; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil., Silva CCF; Immunochemistry Laboratory, Butantan Institute, São Paulo, SP, Brazil., Rodriguez MGP; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil., Carvalho DCOS; Immunochemistry Laboratory, Butantan Institute, São Paulo, SP, Brazil., de Azevedo RA; Experimental Oncology Unit (UNONEX), Federal University of Sao Paulo, Sao Paulo, SP, Brazil., Junior PLS; Mogi das Cruzes University (UMC), Villa Lobos Campus, Sao Paulo, SP, Brazil., Mambelli LI; Department of Immunology, Laboratory of Tumor Immunology, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, SP, Brazil., Portaro FV; Immunochemistry Laboratory, Butantan Institute, São Paulo, SP, Brazil., Pardanaud L; Cardiovascular Research Center and the Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.; INSERM U970, Paris Cardiovascular Research Center, Paris, France., Eichmann A; Cardiovascular Research Center and the Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.; INSERM U970, Paris Cardiovascular Research Center, Paris, France., Sant'Anna OA; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil., Faria M; Special Laboratory of Applied Toxinology, Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo, SP, Brazil.

Publikováno v: Oncotarget [Oncotarget] 2020 Dec 22; Vol. 11 (51), pp. 4770-4787. Date of Electronic Publication: 2020 Dec 22 (Print Publication: 2020).